GeneDx (WGS) has had the highest return since January 1, 2024 by a mid-cap US stock, returning 2,693.7%.
| ASSET | % RETURN |
|---|---|
GeneDx (WGS) | 2,693.7% |
SoundHound AI (SOUN) | 693.9% |
Rigetti Computing (RGTI) | 616% |
Nuscale Power (SMR) | 552.16% |
Janux Therapeutics (JANX) | 472.19% |
ADMA Biologics (ADMA) | 313.11% |
Ast Spacemobile (ASTS) | 300.68% |
Grupo Financiero Galicia SA ADR (GGAL) | 291.62% |
Nextnav Acquisition (NN) | 279.86% |
BBVA Banco Frances SA ADR (BBAR) | 279.08% |
PureCycle Technologies (PCTTW) | 272.81% |
Banco Macro SA B ADR (BMA) | 269.47% |
Lumen Technologies (LUMN) | 263.69% |
Avidity Biosciences (RNA) | 260.2% |
Hims Hers Health (HIMS) | 241.14% |
Longboard Pharmaceuticals (LBPH) | 224.57% |
United States Lime & Minerals (USLM) | 222.75% |
Sweetgreen (SG) | 211.01% |
IES (IESC) | 209.45% |
Rush Street Interactive (RSI) | 207.71% |
Semtech (SMTC) | 200.78% |
Brinker International (EAT) | 198.16% |
Powell Industries (POWL) | 191.16% |
Purecycle Technologies (PCT) | 190.84% |
Vera Therapeutics (VERA) | 189.8% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
